TAMs facilitate the invasion of glioma stem‐like cells to induce the EMT and production of MMP9 and TGF‐β1 to drive tumor progression [120] and promote TGF‐β1/EMT pathways in hepatocellular carcinoma [121]. This evidence concerns the gene TGFB1 and central nervous system cancer.